Pier Luigi Meroni
About
Pier Luigi Meroni is a scholar working on Rheumatology, Immunology and Hematology.
According to data from OpenAlex, Pier Luigi Meroni has authored 621 papers receiving a total of 28.6k indexed citations (citations by other indexed papers that have themselves been cited), including 387 papers in Rheumatology, 209 papers in Immunology and 136 papers in Hematology. Recurrent topics in Pier Luigi Meroni's work include Systemic Lupus Erythematosus Research (341 papers), Monoclonal and Polyclonal Antibodies Research (94 papers) and Platelet Disorders and Treatments (91 papers). Pier Luigi Meroni is often cited by papers focused on Systemic Lupus Erythematosus Research (341 papers), Monoclonal and Polyclonal Antibodies Research (94 papers) and Platelet Disorders and Treatments (91 papers). Pier Luigi Meroni collaborates with scholars based in Italy, United States and Israel. Pier Luigi Meroni's co-authors include Anǵela Tincani, María Orietta Borghi, Elena Raschi, Ricard Cervera, Tatsuya Atsumi, Takayoshi Koike, Y Shoenfeld, Guido Reber, Steven A. Krilis and Michael D. Lockshin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Circulation.
In The Last Decade
Pier Luigi Meroni
602 papers receiving 27.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Pier Luigi Meroni Italy | 81 | 18.0k | 9.0k | 7.6k | 3.7k | 3.1k | 621 | 28.6k | ||
| Munther A. Khamashta United Kingdom | 84 | 22.6k 1.3× | 10.1k 1.1× | 8.7k 1.1× | 4.1k 1.1× | 3.0k 1.0× | 411 | 31.3k | ||
| Ricard Cervera Spain | 79 | 21.8k 1.2× | 8.4k 0.9× | 7.4k 1.0× | 3.8k 1.0× | 3.5k 1.1× | 562 | 29.5k | ||
| Anǵela Tincani Italy | 71 | 15.0k 0.8× | 7.2k 0.8× | 5.9k 0.8× | 2.9k 0.8× | 2.2k 0.7× | 451 | 21.3k | ||
| Michelle Petri United States | 99 | 25.7k 1.4× | 16.7k 1.9× | 3.2k 0.4× | 7.3k 2.0× | 2.0k 0.7× | 534 | 33.5k | ||
| Yoshiya Tanaka Japan | 80 | 14.5k 0.8× | 9.6k 1.1× | 5.2k 0.7× | 3.0k 0.8× | 1.5k 0.5× | 1.1k | 30.4k | ||
| Dennis J. McShane United States | 24 | 27.6k 1.5× | 10.6k 1.2× | 5.1k 0.7× | 5.5k 1.5× | 1.3k 0.4× | 31 | 39.4k | ||
| Philip G. de Groot Netherlands | 76 | 10.1k 0.6× | 4.2k 0.5× | 12.6k 1.6× | 2.6k 0.7× | 2.2k 0.7× | 372 | 25.3k | ||
| Jane G. Schaller United States | 32 | 23.7k 1.3× | 10.5k 1.2× | 6.2k 0.8× | 5.5k 1.5× | 1.5k 0.5× | 91 | 33.2k | ||
| Josef S Smolen Austria | 89 | 25.5k 1.4× | 10.1k 1.1× | 9.6k 1.3× | 3.6k 1.0× | 1.4k 0.5× | 509 | 35.4k | ||
| Frank C. Arnett United States | 67 | 24.3k 1.4× | 9.2k 1.0× | 5.6k 0.7× | 4.8k 1.3× | 2.0k 0.6× | 196 | 37.7k |
Countries citing papers authored by Pier Luigi Meroni
Since
Specialization
Citations
This map shows the geographic impact of Pier Luigi Meroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pier Luigi Meroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pier Luigi Meroni more than expected).
Fields of papers citing papers by Pier Luigi Meroni
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Pier Luigi Meroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pier Luigi Meroni. The network helps show where Pier Luigi Meroni may publish in the future.
Co-authorship network of co-authors of Pier Luigi Meroni
This figure shows the co-authorship network connecting the top 25 collaborators of Pier Luigi Meroni. A scholar is included among the top collaborators of Pier Luigi Meroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pier Luigi Meroni. Pier Luigi Meroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Durigutto, Paolo, et al.. (2025). β2GPI-targeted polymeric nanoparticles form a protective layer to prevent vascular thrombosis in an anti-phospholipid syndrome model. Frontiers in Immunology. 16. 1520619–1520619.
2.
Kumar, Suresh, Paola Adele Lonati, Marta Tonello, et al.. (2025). Domain and residue mapping of autoantibodies to β2GPI reveals differences among antiphospholipid syndrome phenotypes. Blood. 146(26). 3234–3245.
3.
Meroni, Pier Luigi, María Orietta Borghi, O Amengual, et al.. (2024). 2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria solid phase–based antiphospholipid antibody domain—collaborative efforts of Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking and ISTH SSC to harmonize enzyme-linked immunosorbent assay and non–enzyme-linked immunosorbent assay antiphospholipid antibody tests: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. Journal of Thrombosis and Haemostasis. 23(1). 341–344.
4.
Bodio, Caterina, Paola Adele Lonati, Cecilia Beatrice Chighizola, et al.. (2024). Fibroblasts and Endothelial Cells in Three-Dimensional Models: A New Tool for Addressing the Pathogenesis of Systemic Sclerosis as a Prototype of Fibrotic Vasculopathies. International Journal of Molecular Sciences. 25(5). 2780–2780.
5.
Gualtierotti, Roberta, Sharon Fox, Luca Valenti, et al.. (2023). Nailfold Videocapillaroscopic Alterations as Markers of Microangiopathy in COVID-19 Patients. Journal of Clinical Medicine. 12(11). 3727–3727.
6.
Lonati, Paola Adele, Caterina Bodio, Mariangela Scavone, et al.. (2022). Production of anti-PF4 antibodies in antiphospholipid antibody-positive patients is not affected by COVID-19 vaccination. RMD Open. 8(1). e001902–e001902.
7.
Agostinis, Chiara, Paolo Durigutto, Daniele Sblattero, et al.. (2014). A non–complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome. Blood. 123(22). 3478–3487.
8.
Mangano, Katia, Paolo Fagone, Klaus Bendtzen, et al.. (2014). Hypomethylating Agent 5‐Aza‐2′‐deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models. Journal of Cellular Physiology. 229(12). 1918–1925.
9.
Agostinis, Chiara, Paolo Durigutto, Daniele Sblattero, et al.. (2013). A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models.. ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/). 65. 245–245.
10.
Ingegnoli, Francesca, Ennio Giulio Favalli, & Pier Luigi Meroni. (2011). Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to tnf alpha blocking agents? A review analysis of the literature. Autoimmunity Reviews. 10(8). 460–463.
11.
Gerosa, Maria, Barbara Poletti, Francesca Pregnolato, et al.. (2009). Antiphospholipid syndrome and systemic lupus erythematosus patients: what's new about cognitive involvement?. Neurological Sciences. 30.
12.
Mangano, Katia, Niranjan Y. Sardesai, Cinzia Quattrocchi, et al.. (2008). Effects of the immunomodulator, VGX‐1027, in endotoxin‐induced uveitis in Lewis rats. British Journal of Pharmacology. 155(5). 722–730.
13.
Riboldi, Piersandro, Maria Gerosa, Gabriella Moroni, et al.. (2005). Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?. Autoimmunity. 38(1). 39–45.
14.
Meroni, Pier Luigi, Nicoletta Ronda, Elena Raschi, & María Orietta Borghi. (2005). Humoral autoimmunity against endothelium: theory or reality?. Trends in Immunology. 26(5). 275–281.
15.
Gattorno, Marco, Maja Di Rocco, Antonella Buoncompagni, et al.. (2004). Neonatal lupus and a seronegative mother. The Lancet. 363(9414). 1038–1038.
16.
Raschi, Elena, Cinzia Testoni, María Orietta Borghi, Serena Fineschi, & Pier Luigi Meroni. (2003). Endothelium activation in the anti-phospholipid syndrome. Biomedicine & Pharmacotherapy. 57(7). 282–286.
17.
Meroni, Pier Luigi, et al.. (1995). ANTIPHOSPHOLIPID ANTIBODIES AND FETAL LOSS: CLINICAL ASSOCIATION AND POSSIBLE PATHOGENETIC ROLE IN EXPERIMENTAL MODELS. 6. 344–349.
18.
Papa, Nicoletta Del, Pier Luigi Meroni, Wilma Barcellini, et al.. (1992). Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells. Clinical Immunology and Immunopathology. 63(3). 267–274.
19.
Borghi, María Orietta, et al.. (1989). Synergisms between different activation pathways in adult and aged human lymphocytes.. PubMed. 29(3). 133–9.
20.
Barcellini, Wilma, Pier Luigi Meroni, Daniela Frasca, et al.. (1987). Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy.. PubMed Central. 67(3). 537–43.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Munther A. Khamashta Breakdown of academic impact, for papers by Ricard Cervera Breakdown of academic impact, for papers by Anǵela Tincani Breakdown of academic impact, for papers by Michelle Petri Breakdown of academic impact, for papers by Yoshiya Tanaka Breakdown of academic impact, for papers by Dennis J. McShane Breakdown of academic impact, for papers by Philip G. de Groot Breakdown of academic impact, for papers by Jane G. Schaller Breakdown of academic impact, for papers by Josef S Smolen Breakdown of academic impact, for papers by Frank C. Arnett